Toggle Nav
Close
  • Menu
  • Setting

Anti-CD137 & Her2 Antibody (Cinrebafusp alfa)

Catalog No.
F1433
Anti-CD137 & Her2 Antibody (Cinrebafusp alfa)
Grouped product items
SizePriceStock Qty
100ug
$120.00
Ship with 3-5 days
1mg
$360.00
Ship with 3-5 days
5mg
$936.00
Ship with 3-5 days
50mg
$3,145.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Cinrebafusp alfa (PRS 343) is a high-affinity CD137/HER2 bispecific anti-calcitonin drug. Cinrebafusp alfa binds recombinant human HER2 (Kd=0.3 nM) and human monomeric CD137 (4-1BB; Kd=5 nM). Cinrebafusp alfa promotes T cell co-stimulation through tumor-localized HER2-dependent 4-1BB aggregation and activation, further enhancing T cell receptor-mediated activity and leading to tumor destruction. Cinrebafusp alfa has the potential to be used in the study of HER2+ solid tumors.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

187.86 kDa

Shipping

Dry ice

Cas No.

2218515-90-1

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

PRS-343

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q07011 & P04626

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG4

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Human 4-1BB NF-κB Jurkat cells were stained with Anti-CD137 & Her2 Reference Antibody (Cinrebafusp alfa) and negative control protein respectively, washed and then followed by PE and analyzed with FACS

Target

CD137 & Her2

Note

Please avoid freeze-thaw cycles.